Juvéderm VOLUMA XC™ FDA Approved to Treat Volume Loss in the Cheeks
San Diego, CA (PRWEB) October 30, 2013 -- On October 23, 2013, Allergan, Inc. revealed that the FDA just approved Juvéderm VOLUMA XC™ for use as a temporary treatment for volume loss in the cheeks associated with aging. Mitchel P. Goldman, MD, the founder and Medical Director of Goldman, Butterwick, Fitzpatrick, Groff & Fabi: Cosmetic Laser Dermatology in San Diego is excited about this new FDA approval.
“The cheek area is a common source of trouble for patients dealing with facial volume loss. Juvéderm VOLUMA XC™ has shown to be safe and highly effective in filling in cheek hollows for a natural, younger looking result,” said Dr. Goldman.
Juvéderm VOLUMA XC™ is an advanced dermal filler made using Allergan’s revolutionary Vycross™ technology. The filler is a smooth gel that, when injected into the cheek area, lifts the hollow area and produces a plumping effect. Juvéderm VOLUMA XC™ also contains a numbing agent, lidocaine, to make the procedure as comfortable as possible. Both Dr. Goldman and Dr. Kimberly Butterwick, fellow dermatologist at GBFG&F, served as investigators for Allergan in the pivotal FDA study on Voluma.
“Juvéderm VOLUMA XC™ produces a smooth, even result that is desirable for a larger treatment area like the cheeks. This is going to be a great addition to the repertoire of dermal fillers in San Diego already helping us improve the appearance of fine lines and wrinkles,” explained Dr. Mitchel Goldman.
Dr. Goldman is a board-certified dermatologist at Cosmetic Laser Dermatology in San Diego as well as President of the American Society for Dermatologic Surgery who specializes in dermal filler and Botox injections, laser skin treatments, cutting-edge vein therapy, and liposculpture. Cosmetic Laser Dermatology, a team of 5 renowned dermatologists, is known for their commitment to medical research, and Dr. Goldman feels this is what sets them apart.
“We are all actively involved in medical research and clinical trials, which means our patients can be assured that they are receiving the safest, most cutting-edge treatments available in the dermatologic community,” said Dr. Goldman.
Mitchel P. Goldman, MD, is a board certified dermatologist and Diplomate of the American Board of Cosmetic Surgery with a distinctive insight into the performance of both aesthetic and medically necessary dermatologic treatments. As President of the American Society for Dermatologic Surgery and director of the landmark Goldman, Butterwick, Fitzpatrick, Groff & Fabi: Cosmetic Laser Dermatology center in San Diego, Dr. Goldman strives to produce excellent patient care while utilizing the most advanced non-surgical and minimally invasive treatments available.
For more information, contact Cosmetic Laser Dermatology at (858) 605-1897 or visit: http://www.dermalfillersdr.com.
Risa Goldman, Goldman Marketing Group, +1 (818) 861-7092, [email protected]
Share this article